Cite
APA Citation
Shah, N., Tan, A., Budde, L., Hofmeister, C., Cowan, A., Saeed, H., Ye, J., Cairo, M., Rizzieri, D., Orloff, G., Ge, X. S., Lee, Z., Dixit, N., Nieves, W., Vimal, M., Ma, H., Miyazaki, T., Madakamutil, L., Marcondes, M., Lin, W., Tagliaferri, M., Zalevsky, J., & Patel, K. (n.d.). 355 First-in-human phase I study of NKTR-255 in patients with relapsed/refractory hematologic malignancies. Journal for immunotherapy of cancer, 8, A216–A217. http://access.bl.uk/ark:/81055/vdc_100144728730.0x000004